325 related articles for article (PubMed ID: 15878315)
1. Endogenous expression and endocytosis of tartrate-resistant acid phosphatase (TRACP) by osteoblast-like cells.
Perez-Amodio S; Vogels IM; Schoenmaker T; Jansen DC; Alatalo SL; Halleen JM; Beertsen W; Everts V
Bone; 2005 Jun; 36(6):1065-77. PubMed ID: 15878315
[TBL] [Abstract][Full Text] [Related]
2. Endocytosis of tartrate-resistant acid phosphatase by osteoblast-like cells is followed by inactivation of the enzyme.
Perez-Amodio S; Jansen DC; Tigchelaar-Gutter W; Beertsen W; Everts V
Calcif Tissue Int; 2006 Apr; 78(4):248-54. PubMed ID: 16604288
[TBL] [Abstract][Full Text] [Related]
3. Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity.
Collin-Osdoby P; Oursler MJ; Rothe L; Webber D; Anderson F; Osdoby P
J Bone Miner Res; 1995 Jan; 10(1):45-58. PubMed ID: 7747630
[TBL] [Abstract][Full Text] [Related]
4. (Pre-)osteoclasts induce retraction of osteoblasts before their fusion to osteoclasts.
Perez-Amodio S; Beertsen W; Everts V
J Bone Miner Res; 2004 Oct; 19(10):1722-31. PubMed ID: 15355568
[TBL] [Abstract][Full Text] [Related]
5. Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density.
Gradin P; Hollberg K; Cassady AI; Lång P; Andersson G
Cells Tissues Organs; 2012; 196(1):68-81. PubMed ID: 22248481
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk of osteoblast and osteoclast precursors on mineralized collagen--towards an in vitro model for bone remodeling.
Bernhardt A; Thieme S; Domaschke H; Springer A; Rösen-Wolff A; Gelinsky M
J Biomed Mater Res A; 2010 Dec; 95(3):848-56. PubMed ID: 20824694
[TBL] [Abstract][Full Text] [Related]
7. Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro.
Spencer GJ; Utting JC; Etheridge SL; Arnett TR; Genever PG
J Cell Sci; 2006 Apr; 119(Pt 7):1283-96. PubMed ID: 16522681
[TBL] [Abstract][Full Text] [Related]
8. [Effect of the bone resorption supernatant from RAW264.7 osteoclast on the osteogenic activity of mouse MC3T3-E1 cell].
Chen LL; Wang K; Zhang J; Wu YM
Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jan; 47(1):32-7. PubMed ID: 22490219
[TBL] [Abstract][Full Text] [Related]
9. Intracellular machinery for matrix degradation in bone-resorbing osteoclasts.
Vääräniemi J; Halleen JM; Kaarlonen K; Ylipahkala H; Alatalo SL; Andersson G; Kaija H; Vihko P; Väänänen HK
J Bone Miner Res; 2004 Sep; 19(9):1432-40. PubMed ID: 15312243
[TBL] [Abstract][Full Text] [Related]
10. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption.
Halleen JM; Tiitinen SL; Ylipahkala H; Fagerlund KM; Väänänen HK
Clin Lab; 2006; 52(9-10):499-509. PubMed ID: 17078477
[TBL] [Abstract][Full Text] [Related]
11. Induction of osteoclast characteristics in cultured avian blood monocytes; modulation by osteoblasts and 1,25-(OH)2 vitamin D3.
van't Hof RJ; Tuinenburg-Bol Raap AC; Nijweide PJ
Int J Exp Pathol; 1995 Jun; 76(3):205-14. PubMed ID: 7547432
[TBL] [Abstract][Full Text] [Related]
12. Properties and expression of human tartrate-resistant acid phosphatase isoform 5a by monocyte-derived cells.
Janckila AJ; Parthasarathy RN; Parthasarathy LK; Seelan RS; Hsueh YC; Rissanen J; Alatalo SL; Halleen JM; Yam LT
J Leukoc Biol; 2005 Feb; 77(2):209-18. PubMed ID: 15542543
[TBL] [Abstract][Full Text] [Related]
13. Potential function for the ROS-generating activity of TRACP.
Halleen JM; Räisänen SR; Alatalo SL; Väänänen HK
J Bone Miner Res; 2003 Oct; 18(10):1908-11. PubMed ID: 14584905
[TBL] [Abstract][Full Text] [Related]
14. Alkaline phosphatase and tartrate-resistant acid phosphatase in osteoblasts of normal and pathologic bone.
Bonucci E; Nanci A
Ital J Anat Embryol; 2001; 106(2 Suppl 1):129-33. PubMed ID: 11729947
[TBL] [Abstract][Full Text] [Related]
15. Osteoblastic tartrate-resistant acid phosphatase: its potential role in the molecular mechanism of osteogenic action of fluoride.
Lau KH; Baylink DJ
J Bone Miner Res; 2003 Oct; 18(10):1897-900. PubMed ID: 14584902
[TBL] [Abstract][Full Text] [Related]
16. A new heterozygous mutation (R714C) of the osteopetrosis gene, pleckstrin homolog domain containing family M (with run domain) member 1 (PLEKHM1), impairs vesicular acidification and increases TRACP secretion in osteoclasts.
Del Fattore A; Fornari R; Van Wesenbeeck L; de Freitas F; Timmermans JP; Peruzzi B; Cappariello A; Rucci N; Spera G; Helfrich MH; Van Hul W; Migliaccio S; Teti A
J Bone Miner Res; 2008 Mar; 23(3):380-91. PubMed ID: 17997709
[TBL] [Abstract][Full Text] [Related]
17. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
18. Sequence and TLR9 independent increase of TRACP expression by antisense DNA and siRNA molecules.
Muhonen P; Avnet S; Parthasarathy RN; Janckila AJ; Halleen JM; Laitala-Leinonen T; Väänänen HK
Biochem Biophys Res Commun; 2007 Aug; 359(4):889-95. PubMed ID: 17570345
[TBL] [Abstract][Full Text] [Related]
19. Osteoblast-mediated effects of zinc on isolated rat osteoclasts: inhibition of bone resorption and enhancement of osteoclast number.
Holloway WR; Collier FM; Herbst RE; Hodge JM; Nicholson GC
Bone; 1996 Aug; 19(2):137-42. PubMed ID: 8853857
[TBL] [Abstract][Full Text] [Related]
20. Hyperglycemia impairs skeletogenesis from embryonic stem cells by affecting osteoblast and osteoclast differentiation.
Dienelt A; zur Nieden NI
Stem Cells Dev; 2011 Mar; 20(3):465-74. PubMed ID: 20939707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
